Current position: Associate Professor (University of Auckland) and honorary consultant psychiatrist, Waikato District Health Board, Private Bag 3200, Hamilton 3240, New Zealand
David Menkes is an academic psychiatrist with a background in psychology and pharmacology (MD 1982; PhD 1983, Yale). Since completing specialist training in Dunedin (FRANZCP 1989) he has worked as an academic liaison psychiatrist in NZ and the UK. He has research and clinical expertise in the pharmacology of drug treatments in psychiatry, with a particular focus on the adverse effects of psychotropic medications, their interaction with other prescribed drugs and with alcohol. He is a an honorary consultant to the Uppsala Monitoring Centre (WHO Collaborating Centre for International Drug Monitoring), and participates in the Mental Health Sub-committee of the Pharmacology and Therapeutics Advisory Committee (PTAC) that advises New Zealand’s drug purchasing agency (PHARMAC). He has worked with the International Society of Drug Bulletins (www.isdbweb.org) and contributed to the development of its conflict of interest policies.
End-of-Life Care Act: Challenges And Opportunities